Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide National prostatic cancer project randomized trial
- 31 July 1988
- Vol. 32 (1), 33-40
- https://doi.org/10.1016/0090-4295(88)90450-5